The FDA recently recalled Digitek tablets because they could double in thickness and contain twice the amount of the active ingredient. This lawsuit accuses the drug maker of manufacturing defects and failure to warn consumers about the risk. In addition, the company is accused of knowing about the defects and failing to correct them. The attorneys representing the plaintiffs are Cory Watson Crowder & DeGaris, a national law firm recognized for its work in complex litigation, mass torts, and multidistrict litigation.
Digoxin is a form of digoxin
There are several forms of digoxin available. Digoxin oral tablets are available as the brand-name drug Lanoxin. There are also pediatric elixirs for oral administration. Digoxin is given orally and reaches peak serum concentrations in one to three hours. It reaches steady state equilibrium in seven to 12 days. Digoxin should be taken with a meal since it can cause diarrhea if taken with an empty stomach. Also, taking a high-bran-fiber meal may reduce the absorption of digoxin. In addition, concomitant antibiotics may reduce the conversion and cause an increase in serum concentration.
Generally, the recommended dose of digoxin is 0.6 to one mg per kilogram of body weight. The initial dose should be given in several divided doses over six to eight hours, depending on the patient’s weight. Digoxin has several adverse effects that can occur if the serum level of the drug reaches two or more ng/ml. The most common are nausea, anorexia, and diarrhea, as well as headache, weakness, and confusion. During treatment, digoxin serum levels should be checked regularly and safely.
It is used to treat abnormal heart rhythms
Digoxin is a prescription medication used to treat heart failure and chronic atrial fibrillation. In general, adverse effects are less common when used within the recommended dose range and therapeutic serum concentration. However, users should consult with a health care professional if any side effects occur. Some of the most common side effects of Digitek include chest pain, abnormal heart rhythms, and numbness. Also, this drug may interact with other medications or health conditions.
Digoxin interacts with some other drugs and is often recommended for patients with severe heart failure. The drug is also known to cause false positive changes in electrocardiograms due to its tendency to decrease cardiac output. However, these side effects do not necessarily mean that digoxin is a hazard. Digitek may interact with other drugs, such as diuretics and antibiotics. In addition, it passes into breast milk and may cause a false positive on an electrocardiogram.
It is recalled because of a risk of digitalis toxicity
In a recent recall, the maker of Digitek, a prescription drug, recalled tablets that contain double the amount of digitalis that is approved for use in humans. The double dose of digitalis could result in potentially lethal effects in patients with severe kidney failure. The FDA has declared this a Class I recall, which means that the product poses a severe health risk to consumers. This recalled drug could result in low blood pressure, dizziness, nausea, and slow heart rate.
Several people have reported experiencing the side effects of digitalis toxicity after taking Digitek. The manufacturer, Actavis Totowa LLC, is responsible for the recalled medication. Actavis Totowa, formerly known as Amide Pharmaceutical Inc., distributed Digitek to health care providers under the UDL and Bertek brand names. While the company has not stated how long the manufacturing glitch has been in place, it did provide a representative from its regulatory department, Ajordis Arnadottir. Actavis Totowa does not have a corresponding timeline for the recall, but it is unclear whether Digitek was put on the market.
It is recalled in all strengths
A class I recall is being issued for Digitek, a prescription medication. The double-strength tablets contain twice the amount of the active ingredient as is recommended. This could result in serious and potentially life-threatening reactions for patients. The drug was distributed under the brand names Bertek and UDL. This recall is being addressed immediately to protect the public from this potentially dangerous medication. To read more about the recall and how it will affect you, visit the FDA’s recall website.
The manufacturer of Digitek, Actavis Totowa LLC (formerly Amide Pharmaceutical Inc.) has recalled all strength tablets of the drug for safety concerns. The drug’s manufacturer may have accidentally released double-thick pills containing double the normal dose of digoxin, a heart medication used to treat heart arrhythmias. As a precaution, consumers should contact their physician for advice about the safety of Digitek tablets. If you have any concerns or have taken Digitek tablets in the past, contact your physician immediately.
It is recalled because of a risk of digitalis toxicity in patients with renal failure
Actavis Totowa has announced a voluntary recall of certain drug products made by Digitek. The recalled tablets may be twice as thick as required and contain twice the level of active ingredient that is approved for use in patients with renal failure. Patients taking Digitek may experience symptoms of digitalis toxicity including dizziness, low blood pressure, excessive urination, and nausea.
In addition to being a narcotic and a cardiac muscle relaxant, Digitek is also a prescription drug for heart failure and irregular heartbeats. About 50 percent of the digoxin in the United States is affected by the recall, which involves tablets sold under the brands Bertek and UDL Digitek. Actavis received numerous reports about patients experiencing digitalis toxicity. The company first received notification of the potential danger in 2006 and immediately recalled all affected Digitek.